What is the SCAP Score?

The Severe Community-Acquired Pneumonia (SCAP) Score is a structured bedside framework used to identify patients with community-acquired pneumonia (CAP) who are at increased risk of severe clinical deterioration. It is commonly used to support early decisions around level of monitoring, need for higher-acuity care (e.g., ICU or step-down), and escalation of supportive therapy.

SCAP uses a major/minor criteria approach. A patient is considered to meet criteria for severe CAP if they have at least 1 major criterion or at least 2 minor criteria. This design emphasizes early recognition of physiologic compromise and high-risk features rather than relying on a single numeric mortality prediction.

When to consider using SCAP

• Emergency department and initial inpatient evaluation: supports early triage and escalation decisions.
• New CAP diagnosis with borderline vitals or oxygenation: helps identify patients who may deteriorate.
• Disposition planning: complements other tools (e.g., CURB-65, PSI/PORT) by focusing on severe features.
• Communication: provides a standardized way to describe severity risk between clinicians and services.

How SCAP defines “severe CAP”

SCAP classifies severe CAP using the following rule: severe CAP = ≥1 major criterion or ≥2 minor criteria.

Major criteria (any 1 is sufficient)

• Arterial pH < 7.30
• Systolic blood pressure < 90 mmHg

Major criteria represent immediate high-risk physiology. Acidemia can reflect severe systemic illness, respiratory failure, or shock states. Hypotension is an alarm finding for inadequate perfusion and possible septic shock physiology.

Minor criteria (any 2 are sufficient)

• Confusion
• Urea (BUN) > 30 mg/dL (10.71 mmol/L)
• Respiratory rate > 30/min
• Multilobar/bilateral pneumonia on radiography
• PaO₂ < 54 mmHg or PaO₂/FiO₂ < 250
• Age ≥ 80 years

Practical notes on each SCAP variable

Confusion

Confusion captures acute changes in mental status attributable to the current illness. In practice, clinicians often operationalize this as new disorientation, delirium, or significantly altered behavior compared with baseline. Consider confounders such as intoxication, sedating medications, or chronic neurocognitive impairment.

Urea (BUN) > 30 mg/dL

Elevated BUN can be a marker of dehydration, renal dysfunction, catabolic stress, or shock physiology. Ensure units are correct. If using urea in mmol/L, convert appropriately (10.71 mmol/L corresponds to 30 mg/dL BUN as commonly reported in U.S. labs).

Respiratory rate > 30/min

Tachypnea is a sensitive sign of respiratory distress and increased work of breathing. Accurate measurement matters—avoid relying solely on default charted values. Consider reassessing after initial interventions (oxygen, bronchodilators, analgesia) while recognizing that “improved numbers” may not fully reflect physiologic reserve.

Multilobar/bilateral pneumonia on radiography

Multilobar or bilateral involvement suggests higher disease burden and is associated with worse outcomes. Interpretation depends on the imaging modality and timing. Early imaging can underestimate extent; progression over the first 24–48 hours can reveal greater severity.

Hypoxemia: PaO₂ or PaO₂/FiO₂

SCAP includes hypoxemia using either an absolute PaO₂ threshold or an oxygenation ratio threshold:

• PaO₂ < 54 mmHg (arterial blood gas value), or
• PaO₂/FiO₂ < 250

The PaO₂/FiO₂ ratio adjusts for supplemental oxygen and can be especially helpful when patients are not on room air. Use FiO₂ as a fraction (e.g., 0.21 for room air, 0.40 for 40%). As an example, a PaO₂ of 80 mmHg on FiO₂ 0.40 yields a ratio of 200, which meets the minor criterion.

If an ABG is not available, clinicians often use alternative oxygenation measures for bedside monitoring, but SCAP’s hypoxemia criterion specifically uses PaO₂ or PaO₂/FiO₂.

Age ≥ 80 years

Older patients have higher vulnerability and lower physiologic reserve. This criterion intentionally increases sensitivity to severity in advanced age, where deterioration can occur rapidly and atypical presentations are common.

Interpreting SCAP results in workflow

If severe CAP criteria are met

• Monitoring intensity: consider higher-acuity monitoring (ICU/step-down) based on the overall clinical picture.
• Early supportive care: proactively assess for evolving shock, respiratory failure, and need for escalation.
• Reassessment cadence: frequent vital sign and oxygenation reassessment, especially in the first 6–24 hours.
• Team communication: document which major/minor criteria are present to support shared understanding of risk.

If severe CAP criteria are not met

• Reassess over time: CAP severity is dynamic; repeat evaluation if symptoms, oxygenation, or hemodynamics change.
• Use in context: disposition decisions should incorporate comorbidities, functional status, and local standards of care.

Common pitfalls

• Unit mismatches: ensure BUN and PaO₂ units are correct; confirm FiO₂ is entered as a fraction.
• Inaccurate respiratory rate: undercounted tachypnea can falsely reduce assessed severity.
• Baseline mental status: chronic impairment can be misclassified as acute confusion without collateral history.
• Timing effects: imaging and labs early in illness can underestimate severity; repeat if clinical trajectory worsens.
• Over-reliance on a single tool: SCAP supports structured assessment but should not replace bedside judgment.

Limitations and clinical context

• Not a complete management pathway: SCAP helps identify high-risk CAP features but does not specify antibiotic selection, diagnostic testing, or resuscitation protocols.
• Dynamic illness: CAP can worsen after presentation; repeated evaluation is essential even if initial criteria are not met.
• Resource variability: thresholds for ICU/step-down placement vary by institution; align decisions with local practice and capacity.
• Comorbidities and goals of care: consider baseline cardiopulmonary reserve, frailty, and patient preferences when applying results.